
Lower mid-cap valuations near 2006 levels

Multiples paid by both private equity houses and trade buyers for lower mid-cap assets reached their highest level in nearly eight years in Q2, according to the latest Argos Mid-Market Index. Greg Gille reports
Latest News
Riverside carves out HealthTech BioActives from Ferrer
Deal includes three manufacturing facilities located in Spain, which employ around 140 staff
Capvis buys Tertianum Group
GP acquired the care home group from Swiss Prime Site and will be the company's sole shareholder
Iris Capital, Idinvest et al. inject $12.3m into Yubo
Iris, Idinvest and historical backers invest in the manager of the eponymous social media app
Mérieux Equity Partners backs Addmedica
GP uses its Mérieux Participations 3 fund, which held a first close on €200m in 2018
Back to Top